Department of Urology, Roswell Park Cancer Institute, Buffalo, New York 14263, USA.
J Urol. 2011 Feb;185(2):415-20. doi: 10.1016/j.juro.2010.09.071. Epub 2010 Dec 17.
Data regarding clinical outcomes in elderly patients with renal cell carcinoma are scarce. We determined management, and overall and cancer specific survival in elderly patients with renal cell carcinoma.
Using the Surveillance, Epidemiology, and End Results database we identified 59,944 patients who underwent partial or radical nephrectomy for renal cell carcinoma between 1988 and 2005. Patients were separated into 2 groups of those younger than 80 years, and those 80 years old or older, and were stratified by clinical variables. Chi-square, multivariate logistic regression and Kaplan-Meier analyses were used to determine differences between the cohorts in terms of surgical approach, and overall and cancer specific survival.
In total, 4,227 patients (7.5%) were older than 80 years old. Younger patients more likely underwent partial nephrectomy than their older counterparts (13% vs 8%, p <0.001). At a median followup of 37 months (range 0 to 215) for patients younger than 80 years, and 27 months (range 0 to 203) for octogenarians, older patients were 2.32 times more likely to die (95% CI 2.22-2.42, p <0.001) and 1.33 times more likely to die of renal cell carcinoma (95% CI 1.23-1.43, p <0.001) than their younger counterparts. Older patients who underwent radical nephrectomy were 2.54 times more likely to die of renal cell carcinoma (95% CI 1.68-3.84, p <0.001) than older patients who underwent partial nephrectomy.
Older patients are less likely to undergo partial nephrectomy than their younger counterparts. Octogenarians treated with partial nephrectomy are less likely to die of renal cell carcinoma than those who undergo radical nephrectomy.
有关老年肾癌患者临床结局的数据较为匮乏。本研究旨在确定老年肾癌患者的治疗方法以及总生存率和癌症特异性生存率。
利用监测、流行病学和最终结果数据库,我们共鉴定了 1988 年至 2005 年间接受肾部分切除术或根治性肾切除术治疗的 59944 例肾癌患者。根据临床变量将患者分为年龄小于 80 岁和年龄等于或大于 80 岁两组。采用卡方检验、多变量逻辑回归和 Kaplan-Meier 分析比较两组患者的手术方式、总生存率和癌症特异性生存率。
共 4227 例(7.5%)患者年龄大于 80 岁。与年龄小于 80 岁的患者相比,年轻患者更倾向于接受肾部分切除术(13% vs 8%,p<0.001)。在年龄小于 80 岁患者的中位随访时间为 37 个月(范围 0 至 215),年龄等于或大于 80 岁患者的中位随访时间为 27 个月(范围 0 至 203)。与年轻患者相比,年龄大于 80 岁的患者死亡风险高 2.32 倍(95%CI 2.22-2.42,p<0.001),死于肾癌的风险高 1.33 倍(95%CI 1.23-1.43,p<0.001)。与接受肾部分切除术的年龄大于 80 岁患者相比,接受根治性肾切除术的年龄大于 80 岁患者死于肾癌的风险高 2.54 倍(95%CI 1.68-3.84,p<0.001)。
与年轻患者相比,老年患者更倾向于接受根治性肾切除术而非肾部分切除术。接受肾部分切除术的年龄大于 80 岁患者死于肾癌的风险低于接受根治性肾切除术的患者。